SCN5A and myocardial ischemia: These blocking effects, particularly on Nav1.5, although generally deemed to be antiarrhythmic, may also trigger arrhythmias in pathological conditions such as myocardial ischemia or other structural heart diseases by slowing down conduction and favoring reentry [64].